-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613.O2.6 613. Acute Myeloid Leukemia: Clinical and Epidemiological: Outcomes and Omics Potpourri

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, Adults, Epidemiology, Workforce, Health Outcomes Research, Elderly, Health Disparities Research, Diseases, Real World Evidence, Disparities, Myeloid Malignancies, Young Adults, Technology and Procedures, profiling, Study Population, Racial Inequities, Diversity, Equity, and Inclusion (DEI), Clinical Practice (e.g. Guidelines, Health Outcomes and Services, and Survivorship, Value; etc.)
Monday, December 13, 2021: 2:45 PM-4:15 PM
Thomas Murphy Ballroom 1-2, Level 5, Building B (Georgia World Congress Center)
Moderators:
Rory M. Shallis, MD, Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Pinkal Desai, MD, MPH, Weill Cornell Medical College
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Monica Cusan, MD1, Karilyn Larkin, MD2, Deedra Nicolet3,4*, Vindi Jurinovic, PhD5*, Krzysztof Mrózek, MD, PhD6, Aarif M. N. Batcha7*, Klaus H. Metzeler, MD8, Stephanie Schneider9*, Maria Cristina Sauerland, MSc10*, Dennis Görlich, PhD10*, Utz Krug, MD11, Wolfgang E. Berdel, Prof., MD12, Bernhard Josef Woermann13, Wolfgang Hiddemann, MD, PhD8, Jan Braess, MD14*, Karsten Spiekermann, MD15, Jessica Kohlschmidt, PhD3,6, James S. Blachly, MD16, Alice S. Mims, MD17, Christopher J. Walker, PhD18, Christopher C. Oakes, PhD18, Shelley Orwick, B.S.17*, Andrew J Carroll, PhD19, William Blum, MD20, Bayard L. Powell, MD21, Jonathan E Kolitz, MD22, Joseph O. Moore, MD23, Robert James Mayer, MD24, Richard A. Larson, MD25, Richard M. Stone, MD26, John C. Byrd, MD27, Klaus H. Metzeler, MD28, Tobias Herold, MD29 and Ann-Kathrin Eisfeld, MD30,31

1Center for Epigenetic Research, Ludwig-Maximilian University, Munich, Bavaria, Germany
2Division of Hematology, Department of Internal Medicine, Ohio State University Hospital, Columbus, OH
3Alliance Statistics and Data Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH
4Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
5Institute for Medical Informatics, Biometry and Epidemiology, University Hospital, LMU Munich, Munich, Bayern, Germany
6The Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
7Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany
8Department of Medicine III and Comprehensive Cancer Center (CCC Munich LMU), University Hospital, LMU Munich, Munich, Germany
9University of Munich, Laboratory for Leukemia Diagnostics, Munich, Germany
10Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany
11Department of Medicine III, Hospital Leverkusen, Leverkusen, Germany
12Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
13Charité Campus Virchow, Berlin, Germany
14Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany
15Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU, Munich, Germany
16Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
17Division of Hematology, The Ohio State University, Columbus, OH
18The Ohio State University Comprehensive Cancer Center, Columbus, OH
19Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
20Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
21Wake Forest Baptist Health Comprehensive Cancer Center, Winston Salem, NC
22Monter Cancer Center, Northwell Health, Lake Success, NY
23Duke University Medical Center, Durham, NC
24Dana-Farber Cancer Inst., Boston, MA
25Comprehensive Cancer Center, University of Chicago, Chicago, IL
26Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
27Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH
28Department of Hematology, Cell Therapy and Hemostaseology, University of Munich, Leipzig, Germany
29Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital, Munich, Bavaria, Germany
30Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
31The Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH

3:00 PM

Onyee Chan, MD1, Najla Al Ali, MS2, Hammad Tashkandi, MD3*, Austin Ellis, MD3*, Somedeb Ball, MD4*, Ling Zhang, MD5*, Mohammad Hussaini, MD3*, Jinming Song, MD, PhD6*, Seongseok Yun, MD, PhD1, Chetasi Talati, MD7*, Andrew T. Kuykendall, MD1, Eric Padron, MD2, David A. Sallman, MD1, Kendra Sweet, MD1, Rami S. Komrokji, MD2 and Jeffrey E. Lancet, MD1

1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Pathology, Moffitt Cancer Center, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
5Department of Hematopathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6Department of Hematopathology, Moffitt Cancer Center, Tampa, FL
7Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL

3:15 PM

Pallavi Galera1*, Alexander Chan2*, Andriy Derkach, PhD3*, Ying Liu1*, Jeeyeon Baik4*, Christopher Famulare, MS5*, Allison Sigler1*, Maria E. Arcila, MD6*, Douglas A Mata1*, Ahmet Dogan, MD, PhD7, Martin S. Tallman, MD8, Ross L. Levine, MD9, Yanming Zhang, MD10, Mikhail Roshal, MD, PhD4, Jacob L Glass, MD, PhD9 and Wenbin Xiao4

1Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Pathology, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
5Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
6Molecular Diagnostic Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Pathology, Hematopathology Service, Memorial Sloan-Kettering Cancer Center, New York, NY
8Memorial Sloan-Kettering Cancer Center, New York, NY
9Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
10Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY

3:30 PM

Armin Rashidi, MD, PhD1, Maryam Ebadi, MD2, Tauseef Ur Rehman, MD2*, Heba Elhusseini, MD2*, Harika Nalluri3*, Thomas Kaiser4*, Sivapriya Ramamoorthy5*, Shernan G Holtan, MD1, Alexander Khoruts, MD6*, Daniel J. Weisdorf, MD2 and Christopher Staley, PhD4*

1Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
2Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
3Department of surgery, University of Minnesota, Minneapolis, MN
4Department of Surgery, University of Minnesota, Minneapolis, MN
5Metabolon, Inc., Morrisville, NC
6Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN

3:45 PM

Scott C Howard, MD, MSc1, Drew Watson, Ph.D.2*, Michael Castro, MD2*, Shweta Kapoor, M.Sc.2*, Prashant Ramachandran Nair, B.Tech.2*, Samiksha Avinash Prasad, M.Sc.2*, Swaminathan Rajagopalan, M.Tech.2*, Aftab Alam, M.Sc.2*, Kunal Ghosh Roy, M.Sc.2*, Diwyanshu Sahu, M.Sc.2*, Deepak Anil Lala, B.Tech.2*, Kabya Basu, M.Sc.2*, Yashaswini S Ullal, M.Tech.2*, Yugandhara Narvekar, M.Sc.2*, Adity Ghosh, M.Sc.2*, Mohammed Sauban, B.E.2*, Poornachandra G, B.Tech.2*, Ashish Kumar Agrawal, B.V.Sc, A.H.2*, Anuj Tyagi, M.Sc.2*, Rakhi Purushothaman Suseela, B.Tech.2*, Karthik Sundara Raju, M.Sc.2*, Anusha Pampana, M.Sc.2*, Sanjana Patel, MSc2*, Nirjhar Mundkur, B.S2*, James Christie, B.S.2*, Michele Dundas Macpherson, B.A.Sc.2* and Guido Marcucci, MD3

1Department of Acute and Tertiary Care, University of Tennessee Health Science Center, Memphis, TN
2Cellworks Group Inc., South San Francisco, CA
3Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope, Duarte, CA

4:00 PM

Chezi Ganzel1,2*, Kevin Roopcharan3*, Zhuoxin Sun, PhD4,5*, Jacob M. Rowe, MD6*, Hugo F Fernandez7*, Elisabeth M. Paietta, PhD8*, Selina M. Luger, MD, FRCPC9,10, Hillard M Lazarus, MD11,12, Larry D Cripe, MD13*, Dan Douer, MD14, Peter H. Wiernik, MD15, Martin S. Tallman, MD16,17 and Mark R. Litzow, MD18

1Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
2Shaare Zedek Medical Center, Jerusalem, Israel
3Dana Farber Cancer Institute – ECOG-ACRIN Biostatistics Center, Boston, MA
4Dana-Farber Cancer Institute, Boston, MA
5Dana Farber Cancer Institute, ECOG-ACRIN Statistical Center, Boston, MA
6Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
7Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Pembroke Pines
8Albert Einstein College of Medicine, New York, NY
9Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
10Cellular Therapy and Transplantation, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
11Case Western Reserve University School of Medicine, Cleveland, OH
12Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Cleveland Medical Center, Shaker Heights, OH
13Indiana University Simon Cancer Center, Indianapolis, IN
14Dept. of Hematology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA
15Cancer Research Foundation, Chappaqua, NY
16Memorial Sloan-Kettering Cancer Center, New York, NY
17Weill Cornell Medical College, New York, NY
18Division of Hematology, Mayo Clinic, Rochester, MN

*signifies non-member of ASH